We are live on ! Find out more
M

Mirova Portfolio holdings

AUM $2.46B
1-Year Est. Return 11.42%
This Fund
S&P 500
This Quarter Est. Return
-0.67%
1 Year Est. Return
+11.42%
3 Year Est. Return
+32%
5 Year Est. Return
+23.08%
10 Year Est. Return
AUM
$838M
AUM Growth
+$60.6M
Cap. Flow
+$77.6M
Cap. Flow %
9.26%
Top 10 Hldgs %
73.46%
Holding
171
New
7
Increased
143
Reduced
13
Closed
7

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$39.5M
2
WOLF icon
Wolfspeed
WOLF
+$36.9M
3
ENPH icon
Enphase Energy
ENPH
+$30.7M
4
RUN icon
Sunrun
RUN
+$21.9M
5
ECL icon
Ecolab
ECL
+$6.17M

Top Sells

Rank Stock Value
1
ITRI icon
Itron
ITRI
+$46.4M
2
WTRG icon
Essential Utilities
WTRG
+$23.6M
3
FSLR icon
First Solar
FSLR
+$11.1M
4
DHR icon
Danaher
DHR
+$9.26M
5
APD icon
Air Products & Chemicals
APD
+$3.91M

Sector Composition

Rank Sector Weight
1 Technology 35.71%
2 Healthcare 22.14%
3 Materials 16.42%
4 Industrials 11.42%
5 Financials 4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
26
Stryker
SYK
$132B
$3.72M 0.44%
15,273
+2,137
+16% +$512K
ISRG icon
27
Intuitive Surgical
ISRG
$131B
$3.71M 0.44%
15,051
+456
+3% +$115K
ANSS
28
DELISTED
Ansys
ANSS
$3.4M 0.41%
10,027
+6,475
+182% +$2.3M
CRM icon
29
Salesforce
CRM
$150B
$3.33M 0.4%
15,721
+1,064
+7% +$237K
IFF icon
30
International Flavors & Fragrances
IFF
$20.1B
$3.18M 0.38%
22,751
+6,702
+42% +$867K
CL icon
31
Colgate-Palmolive
CL
$75B
$3.16M 0.38%
40,044
+12,287
+44% +$963K
GDDY icon
32
GoDaddy
GDDY
$13.4B
$3M 0.36%
+38,633
New +$3.11M
IP icon
33
International Paper
IP
$23.4B
$2.92M 0.35%
57,122
+14,708
+35% +$716K
BFAM icon
34
Bright Horizons
BFAM
$4.24B
$2.87M 0.34%
16,739
+2,276
+16% +$375K
WDAY icon
35
Workday
WDAY
$39.1B
$2.74M 0.33%
11,041
+2,926
+36% +$723K
AXP icon
36
American Express
AXP
$227B
$2.68M 0.32%
+18,964
New +$2.51M
SPLK
37
DELISTED
Splunk Inc
SPLK
$2.68M 0.32%
19,755
+10,813
+121% +$1.69M
SYF icon
38
Synchrony
SYF
$25B
$2.61M 0.31%
+64,237
New +$2.48M
ARRY icon
39
Array Technologies
ARRY
$777M
$2.54M 0.3%
+85,214
New +$3.4M
FTCH
40
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$2.53M 0.3%
47,751
+4,986
+12% +$305K
MRK icon
41
Merck
MRK
$326B
$2.52M 0.3%
34,216
+4,918
+17% +$363K
MET icon
42
MetLife
MET
$62.4B
$2.44M 0.29%
40,081
+4,431
+12% +$245K
HD icon
43
Home Depot
HD
$344B
$2.33M 0.28%
7,633
+1,208
+19% +$333K
NEO icon
44
NeoGenomics
NEO
$1.75B
$2.32M 0.28%
48,053
+22,545
+88% +$1.17M
XIFR
45
XPLR Infrastructure LP
XIFR
$1.1B
$2.21M 0.26%
30,349
+6,536
+27% +$503K
IBM icon
46
IBM
IBM
$213B
$2.15M 0.26%
16,881
-2,117
-11% -$253K
LUMN icon
47
Lumen
LUMN
$6.32B
$2.07M 0.25%
155,392
+12,957
+9% +$161K
KMB icon
48
Kimberly-Clark
KMB
$37.7B
$2.03M 0.24%
14,587
+2,527
+21% +$335K
MNTV
49
DELISTED
Momentive Global Inc. Common Stock
MNTV
$1.95M 0.23%
106,632
+57,420
+117% +$1.29M
LULU icon
50
lululemon athletica
LULU
$13.7B
$1.86M 0.22%
6,068
+730
+14% +$240K

Similar funds

Mirova's Q1 2021 Portfolio in Review

As of Q1 2021, Mirova held 171 positions worth $838M, up 7.8% from $778M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Mirova deployed $77.6M of net new capital in Q1 2021, opening 7 new positions and adding to 143 existing holdings. Its largest new stake was Array Technologies: 85,214 shares worth $2.54M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Itron, an estimated $46.4M trimmed.

  • Mirova's largest Q1 2021 buy was Array Technologies: 85,214 shares worth $2.54M.
  • Mirova added most to Thermo Fisher Scientific in Q1 2021, an estimated $39.5M increase.
  • Mirova's biggest Q1 2021 reduction was Itron, cutting an estimated $46.4M.
  • Mirova fully exited Tiffany & Co. in Q1 2021, selling an estimated $380K.
  • Mirova's ten largest holdings make up 73% of its $838M portfolio in Q1 2021.
  • Mirova opened 7 new positions and closed 7 in Q1 2021.
  • Mirova's portfolio value rose 7.8% quarter-over-quarter to $838M.

Based on Mirova's 13F filing for Q1 2021, filed 14 May 2021.